{"id":62728,"date":"2026-03-03T10:06:22","date_gmt":"2026-03-03T09:06:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/"},"modified":"2026-03-03T10:06:22","modified_gmt":"2026-03-03T09:06:22","slug":"dxcover-secures-ce-ivdr-certification","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/","title":{"rendered":"Dxcover Secures CE-IVDR Certification"},"content":{"rendered":"
\n

\nKey Milestone Signals Readiness for Regulated Diagnostic Deployment<\/b><\/p>\n

GLASGOW, Scotland–(BUSINESS WIRE)–Dxcover, a global leader in AI-enabled technologies, today announced that its breakthrough liquid biopsy medical device has successfully achieved CE marking under the European In Vitro Diagnostic Regulation (IVDR) (EU) 2017\/746.<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cThis validates not just a single product, but the underlying rigor of our infrastructure \u2014 from software architecture and data pipelines to clinical evidence and quality processes,\u201d said Matthew Baker PhD, CEO & co-Founder, Dxcover. \u201cIt de-risks Dxcover\u2019s ability to scale its technology across multiple clinical applications, an important step in furthering Dxcover\u2019s mission to detect cancer early and benefit patients.\u201d<\/p>\n

\nDxcover now becomes one of the bold leaders leveraging AI and machine-learning into its IVDR-compliant Class C medical device software. CE-mark for a Class C device is granted to diagnostic devices delivering results that are highly significant for patient care and treatment decisions. Achieving CE-IVDR Class C status reflects compliance with one of the most stringent regulatory standards in Europe.<\/b><\/p>\n

\n\u201cDxcover\u2019s technology represents a step-change in diagnostic approach. But disruptive innovation can only be realized in practice when subject to the highest levels of regulatory scrutiny, which is why we are delighted to have reached this milestone,\u201d added David Eustace PhD, General Manager, Dxcover. \u201cThis high impact certification provides the most solid of regulatory foundations to support commercialization and future growth.\u201d<\/p>\n

\nAbout Dxcover<\/b><\/p>\n

\nDxcover is changing how early, how accurately, and how efficiently cancer can be detected. The company\u2019s platform integrates infrared spectroscopy data with proprietary algorithms to support earlier and more actionable clinical insights from a small amount of blood, yielding results in hours instead of weeks. AI-powered insight, delivered at light speed.<\/p>\n

\nFurther Information:<\/b> https:\/\/www.dxcover.com\/<\/a><\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:<\/b> info@dxcover.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Key Milestone Signals Readiness for Regulated Diagnostic Deployment GLASGOW, Scotland–(BUSINESS WIRE)–Dxcover, a global leader in AI-enabled technologies, today announced that its breakthrough liquid biopsy medical device has successfully achieved CE marking under the European In Vitro Diagnostic Regulation (IVDR) (EU) 2017\/746. \u201cThis validates not just a single product, but the underlying rigor of our infrastructure … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62728","6":"format-standard","7":"category-industry"},"yoast_head":"\nDxcover Secures CE-IVDR Certification - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dxcover Secures CE-IVDR Certification - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Key Milestone Signals Readiness for Regulated Diagnostic Deployment GLASGOW, Scotland–(BUSINESS WIRE)–Dxcover, a global leader in AI-enabled technologies, today announced that its breakthrough liquid biopsy medical device has successfully achieved CE marking under the European In Vitro Diagnostic Regulation (IVDR) (EU) 2017\/746. \u201cThis validates not just a single product, but the underlying rigor of our infrastructure ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-03T09:06:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260303995618\/en\/2128574\/22\/Dxcover_logo_1.25x.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dxcover-secures-ce-ivdr-certification\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dxcover-secures-ce-ivdr-certification\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Dxcover Secures CE-IVDR Certification\",\"datePublished\":\"2026-03-03T09:06:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dxcover-secures-ce-ivdr-certification\\\/\"},\"wordCount\":296,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dxcover-secures-ce-ivdr-certification\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260303995618\\\/en\\\/2128574\\\/22\\\/Dxcover_logo_1.25x.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dxcover-secures-ce-ivdr-certification\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dxcover-secures-ce-ivdr-certification\\\/\",\"name\":\"Dxcover Secures CE-IVDR Certification - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dxcover-secures-ce-ivdr-certification\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dxcover-secures-ce-ivdr-certification\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260303995618\\\/en\\\/2128574\\\/22\\\/Dxcover_logo_1.25x.jpg\",\"datePublished\":\"2026-03-03T09:06:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dxcover-secures-ce-ivdr-certification\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dxcover-secures-ce-ivdr-certification\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dxcover-secures-ce-ivdr-certification\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260303995618\\\/en\\\/2128574\\\/22\\\/Dxcover_logo_1.25x.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260303995618\\\/en\\\/2128574\\\/22\\\/Dxcover_logo_1.25x.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dxcover-secures-ce-ivdr-certification\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dxcover Secures CE-IVDR Certification\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dxcover Secures CE-IVDR Certification - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/","og_locale":"en_US","og_type":"article","og_title":"Dxcover Secures CE-IVDR Certification - Pharma Trend","og_description":"Key Milestone Signals Readiness for Regulated Diagnostic Deployment GLASGOW, Scotland–(BUSINESS WIRE)–Dxcover, a global leader in AI-enabled technologies, today announced that its breakthrough liquid biopsy medical device has successfully achieved CE marking under the European In Vitro Diagnostic Regulation (IVDR) (EU) 2017\/746. \u201cThis validates not just a single product, but the underlying rigor of our infrastructure ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/","og_site_name":"Pharma Trend","article_published_time":"2026-03-03T09:06:22+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260303995618\/en\/2128574\/22\/Dxcover_logo_1.25x.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Dxcover Secures CE-IVDR Certification","datePublished":"2026-03-03T09:06:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/"},"wordCount":296,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260303995618\/en\/2128574\/22\/Dxcover_logo_1.25x.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/","url":"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/","name":"Dxcover Secures CE-IVDR Certification - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260303995618\/en\/2128574\/22\/Dxcover_logo_1.25x.jpg","datePublished":"2026-03-03T09:06:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260303995618\/en\/2128574\/22\/Dxcover_logo_1.25x.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260303995618\/en\/2128574\/22\/Dxcover_logo_1.25x.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/dxcover-secures-ce-ivdr-certification\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Dxcover Secures CE-IVDR Certification"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62728","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62728"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62728\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62728"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62728"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62728"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}